Raymond James & Associates’s Rocket Lab Corp RKLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$589K Buy
60,545
+35,091
+138% +$213K ﹤0.01% 3008
2024
Q2
$122K Buy
25,454
+2,584
+11% +$10.8K ﹤0.01% 3703
2024
Q1
$94K Buy
22,870
+1,045
+5% +$4.82K ﹤0.01% 3742
2023
Q4
$121K Buy
21,825
+2,040
+10% +$9.21K ﹤0.01% 3621
2023
Q3
$86.7K Sell
19,785
-2,400
-11% -$14.6K ﹤0.01% 3621
2023
Q2
$133K Sell
22,185
-12,475
-36% -$57.2K ﹤0.01% 3570
2023
Q1
$140K Sell
34,660
-5,400
-13% -$24.2K ﹤0.01% 3577
2022
Q4
$151K Sell
40,060
-12,796
-24% -$55.9K ﹤0.01% 3534
2022
Q3
$215K Sell
52,856
-15,223
-22% -$75.1K ﹤0.01% 3403
2022
Q2
$258K Buy
68,079
+630
+0.9% +$3.71K ﹤0.01% 3333
2022
Q1
$543K Buy
67,449
+1,573
+2% +$14.6K ﹤0.01% 3025
2021
Q4
$809K Buy
65,876
+7,058
+12% +$97K ﹤0.01% 2765
2021
Q3
$949K Buy
+58,818
New +$707K ﹤0.01% 2617

Other funds holding RKLB

Raymond James & Associates's RKLB Position: Q3 2024 in Review

Raymond James & Associates increased its Rocket Lab Corp (RKLB) stake by 138% in Q3 2024, buying an estimated $213K and bringing the position to 60,545 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #3008.

Raymond James & Associates first reported a position in RKLB in Q3 2021 and has held it in 13 quarters since. The position peaked at $949K in Q3 2021. 285 funds tracked by Wall St. Rank hold RKLB as of Q3 2024.

  • Raymond James & Associates held 60,545 shares of Rocket Lab Corp worth $589K as of Q3 2024.
  • Raymond James & Associates bought 35,091 Rocket Lab Corp shares in Q3 2024, an estimated $213K.
  • Rocket Lab Corp made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3008 holding.
  • Raymond James & Associates first reported a position in Rocket Lab Corp in Q3 2021 and has held it in 13 quarters since.
  • Raymond James & Associates's Rocket Lab Corp position peaked at $949K in Q3 2021.
  • 285 funds tracked by Wall St. Rank held Rocket Lab Corp as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.